128 related articles for article (PubMed ID: 20078623)
1. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure.
Mansour IN; Napan S; Tarek Alahdab M; Stamos TD
Congest Heart Fail; 2010; 16(1):15-20. PubMed ID: 20078623
[TBL] [Abstract][Full Text] [Related]
2. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
3. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
4. Value of BNP and tumour marker CA125 in patients with heart failure.
Chen YX; Wang XQ; Fang CF; Wang JF; Tang LJ
Acta Cardiol; 2008 Aug; 63(4):501-6. PubMed ID: 18795589
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction.
Falcão F; Oliveira F; Cantarelli F; Cantarelli R; Brito Júnior P; Lemos H; Silva P; Camboim I; Freire MC; Carvalho O; Sobral Filho DC
Sci Rep; 2020 Jul; 10(1):11016. PubMed ID: 32620821
[TBL] [Abstract][Full Text] [Related]
6. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
[TBL] [Abstract][Full Text] [Related]
10. Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure.
Alahdab MT; Mansour IN; Napan S; Stamos TD
J Card Fail; 2009 Mar; 15(2):130-5. PubMed ID: 19254672
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.
Kouris NT; Kontogianni DD; Papoulia EP; Goranitou GS; Zaharos ID; Grassos HA; Kalkandi EM; Sifaki MD; Babalis DK
Hellenic J Cardiol; 2006; 47(5):269-74. PubMed ID: 17134062
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic value of elevated CA125 levels in patients with coronary heart disease.
Rong X; Yunke Z; Guoping L; Zhenyue C
Herz; 2015 Jun; 40(4):690-4. PubMed ID: 24831034
[TBL] [Abstract][Full Text] [Related]
15. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure.
Núñez J; Núñez E; Sanchis J; Bodí V; Fonarow GC; Miñana G; Palau P; Bertomeu-González V; Carratalá A; Mainar L; Chorro FJ; Llàcer A
Int J Cardiol; 2012 Aug; 159(1):21-8. PubMed ID: 21367474
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Schmid H; Trenkwalder T; Mayr NP; Joner M; Kasel AM; Holdenrieder S; Nunez J; Sanchis J; Bodi V; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Am J Cardiol; 2018 Feb; 121(4):461-468. PubMed ID: 29306485
[TBL] [Abstract][Full Text] [Related]
17. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
18. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
19. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]